Outcomes of Transvenous Lead Extraction for Infectious Versus Non‐Infectious Indications
Pacing and Clinical Electrophysiology · 2026-11-11
DOI: 10.1111/pace.70496 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2026-11-11. Written by Adivitch Sripusanapan and 6 co-authors. Institution: Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA. 38 references.
Abstract (original language)
Background
Transvenous lead extraction (TLE) is performed for both infectious and non‐infectious cardiac implantable electronic device (CIED) indications. Infectious indications are associated with greater systemic illness, whereas non‐infectious leads are generally older and more fibrotic. Whether these competing factors differentially influence TLE outcomes remains unclear.
Methods
We searched PubMed, Embase, Scopus, and CENTRAL through October 10, 2026 for studies directly comparing TLE outcomes between infectious and non‐infectious indications. Trial registries, conference abstracts, and preprint servers were screened. The primary outcome was all‐cause mortality. Secondary outcomes included procedural success and complications. Random‐effects models were used.
Results
Fifteen observational studies comprising 53,086 patients were included. Infectious indications were associated with higher all‐cause mortality (OR 5.61, 95% CI 3.78–8.33; I 2 = 82.3%). The association was greater for short‐term than long‐term mortality (OR 8.57 vs. 2.67; p for interaction < 0.001). Intermediate‐term mortality was also higher (OR 3.84, 95% CI 2.50–5.91). Pericardial complications were less frequent with infectious indications (OR 0.71, 95% CI 0.53–0.95). Clinical and complete procedural success and other complications did not differ significantly.
Conclusion
Infectious indications were associated with higher mortality, particularly in the short term, whereas procedural success was comparable. Variation in follow‐up and infection phenotype likely contributed to heterogeneity.
Subjects
Author keywords
Authors and institutions
- Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Cardiovascular Medicine, Department of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Center of Excellence in Arrhythmia Research, Cardiac Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Department of Cardiovascular Medicine, Pali Momi Medical Center, Hawaii, Pacific Health, Aiea, Hawaii, USA.
- Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
ORCID profiles: Adivitch Sripusanapan, Natee Deepan, Narut Prasitlumkum, Pattara Rattanawong, Jakrin Kewcharoen
Cite
APA
Sripusanapan, A., Deepan, N., Charoenpoonsiri, N., Prasitlumkum, N., Rattanawong, P., Jongnarangsin, K., & Kewcharoen, J. (2026). Outcomes of Transvenous Lead Extraction for Infectious Versus Non‐Infectious Indications. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70496
Vancouver
Sripusanapan A, Deepan N, Charoenpoonsiri N, Prasitlumkum N, Rattanawong P, Jongnarangsin K, et al. Outcomes of Transvenous Lead Extraction for Infectious Versus Non‐Infectious Indications. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70496
BibTeX
@article{Sripusanapan2026,
author = {Sripusanapan, Adivitch and Deepan, Natee and Charoenpoonsiri, Nattawat and Prasitlumkum, Narut and Rattanawong, Pattara and Jongnarangsin, Krit and Kewcharoen, Jakrin},
title = {Outcomes of Transvenous Lead Extraction for Infectious Versus Non‐Infectious Indications},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70496}
}
EUVIMED